这是一篇来自已证抗体库的有关人类 ICAM-1 (ICAM-1) 的综述,是根据116篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合ICAM-1 抗体。
ICAM-1 同义词: BB2; CD54; P3.58

赛默飞世尔
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔ICAM-1抗体(eBioscience, 17-0549-42)被用于被用于流式细胞仪在人类样本上 (图 3b). elife (2019) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔ICAM-1抗体(eBioscience, HA58)被用于被用于流式细胞仪在人类样本上 (图 5a). Front Immunol (2019) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔ICAM-1抗体(Invitrogen, MHCD5401-4)被用于被用于流式细胞仪在人类样本上 (图 1b). Clin Sci (Lond) (2017) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 1:50; 图 st2
赛默飞世尔ICAM-1抗体(Caltag, mhcd5401)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 st2). Sci Rep (2017) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 表 3
赛默飞世尔ICAM-1抗体(Invitrogen, MEM-111)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔ICAM-1抗体(Invitrogen, HA58)被用于被用于流式细胞仪在人类样本上 (表 1). PLoS ONE (2016) ncbi
小鼠 单克隆(R6.5)
  • 其他; 人类; 图 2b
赛默飞世尔ICAM-1抗体(eBiosciences, BMS1011)被用于被用于其他在人类样本上 (图 2b). J Immunol Methods (2016) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔ICAM-1抗体(Invitrogen, MHCD5401)被用于被用于流式细胞仪在人类样本上 (图 1). Front Physiol (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, HA58)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2016) ncbi
小鼠 单克隆(RR1/1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔ICAM-1抗体(eBioscience, BMS108FI)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Cell Biochem (2016) ncbi
小鼠 单克隆(R6.5)
  • 其他; 人类; 图 2
赛默飞世尔ICAM-1抗体(eBioscience, BMS1011)被用于被用于其他在人类样本上 (图 2). J Extracell Vesicles (2015) ncbi
小鼠 单克隆(1H4)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(生活技术, A15748)被用于被用于流式细胞仪在人类样本上. J Interferon Cytokine Res (2015) ncbi
domestic rabbit 重组(9H21L19)
  • 免疫印迹; 人类; 图 5
赛默飞世尔ICAM-1抗体(Thermo, 9H21L19)被用于被用于免疫印迹在人类样本上 (图 5). Eur J Med Res (2015) ncbi
小鼠 单克隆(RR1/1)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, RR1/1)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, HA58)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, HA58)被用于被用于流式细胞仪在人类样本上. Arthritis Res Ther (2014) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔ICAM-1抗体(eBioscience, clone HA58)被用于被用于流式细胞仪在人类样本上 (图 6). Leuk Res (2014) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, HA58)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(9HCLC)
  • 免疫细胞化学; 人类; 1:250
  • 免疫印迹; 人类
赛默飞世尔ICAM-1抗体(Invitrogen, 710278)被用于被用于免疫细胞化学在人类样本上浓度为1:250 和 被用于免疫印迹在人类样本上. Proteome Sci (2014) ncbi
小鼠 单克隆(RR1/1)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(eBioscience, BMS108FI)被用于被用于流式细胞仪在人类样本上. Br J Pharmacol (2014) ncbi
小鼠 单克隆(6G12)
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔ICAM-1抗体(Zymed, 6G12)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. J Oral Pathol Med (2014) ncbi
小鼠 单克隆(MEM-111)
  • 免疫组化; 人类; 图 3
赛默飞世尔ICAM-1抗体(Invitrogen, MHCD5401)被用于被用于免疫组化在人类样本上 (图 3). Blood Cancer J (2013) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔ICAM-1抗体(Caltag, MEM111)被用于被用于流式细胞仪在人类样本上 (图 3). Int J Hematol (2011) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔ICAM-1抗体(Caltag, MEM 111)被用于被用于流式细胞仪在人类样本上 (图 4). Placenta (2011) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔ICAM-1抗体(Caltag, MEM-111)被用于被用于流式细胞仪在人类样本上 (图 6). J Infect Dis (2010) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔ICAM-1抗体(Caltag, MEM-111)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2007) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(Caltag, MEM-111)被用于被用于流式细胞仪在人类样本上. Am J Clin Pathol (2006) ncbi
小鼠 单克隆(84H10)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔ICAM-1抗体(Caltag, 84H10)被用于被用于流式细胞仪在人类样本上 (表 1). J Cell Physiol (2006) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔ICAM-1抗体(Caltag, MEM-111)被用于被用于流式细胞仪在人类样本上 (图 6). J Biol Chem (2005) ncbi
小鼠 单克隆(84H10)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔ICAM-1抗体(Caltag, 84H10)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol Methods (2005) ncbi
小鼠 单克隆(84H10)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(Caltag, 84H10)被用于被用于流式细胞仪在人类样本上. J Cell Physiol (2005) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔ICAM-1抗体(Caltag, MEM111)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2003) ncbi
小鼠 单克隆(1A29)
  • 免疫组化; 大鼠; 1:50; 图 3
  • 免疫印迹; 大鼠; 1:50; 图 5
赛默飞世尔ICAM-1抗体(Caltag, 1A29)被用于被用于免疫组化在大鼠样本上浓度为1:50 (图 3) 和 被用于免疫印迹在大鼠样本上浓度为1:50 (图 5). Muscle Nerve (2002) ncbi
小鼠 单克隆(MEM-111)
  • 流式细胞仪; 人类
赛默飞世尔ICAM-1抗体(Caltag, MEM111)被用于被用于流式细胞仪在人类样本上. Infect Immun (2001) ncbi
圣克鲁斯生物技术
小鼠 单克隆(G-5)
  • 免疫细胞化学; 人类; 1:50; 图 2s2d
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-8439)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 2s2d). elife (2020) ncbi
小鼠 单克隆(G-5)
  • 免疫组化-石蜡切片; 小鼠; 图 s14b
圣克鲁斯生物技术ICAM-1抗体(Santa, SC-8439)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s14b). Science (2018) ncbi
小鼠 单克隆(G-5)
  • 免疫印迹; 人类; 1:400; 图 8c
圣克鲁斯生物技术ICAM-1抗体(SantaCruz, sc-8439)被用于被用于免疫印迹在人类样本上浓度为1:400 (图 8c). Am J Physiol Heart Circ Physiol (2018) ncbi
小鼠 单克隆(15.2)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术ICAM-1抗体(Santa cruz, Sc-107)被用于被用于免疫印迹在人类样本上 (图 5). PLoS Genet (2017) ncbi
小鼠 单克隆(6.5B5)
  • 免疫印迹; 小鼠; 图 1d
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-18853)被用于被用于免疫印迹在小鼠样本上 (图 1d). Redox Biol (2017) ncbi
小鼠 单克隆(G-5)
  • 免疫印迹; 人类; 1:1000; 图 2d
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-8439)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2d). Oncotarget (2017) ncbi
小鼠 单克隆(G-5)
  • 免疫组化-石蜡切片; 大鼠; 1:325; 图 4d
  • 免疫印迹; 大鼠; 1:325
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-8439)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:325 (图 4d) 和 被用于免疫印迹在大鼠样本上浓度为1:325. Front Pharmacol (2016) ncbi
小鼠 单克隆(15.2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, SC-107)被用于被用于免疫印迹在人类样本上 (图 1). J Inflamm (Lond) (2016) ncbi
小鼠 单克隆(15.2)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-107)被用于被用于免疫印迹在人类样本上 (图 5). Orphanet J Rare Dis (2016) ncbi
小鼠 单克隆(G-5)
  • 免疫印迹; 人类; 图 3B
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-8439)被用于被用于免疫印迹在人类样本上 (图 3B). PLoS ONE (2016) ncbi
小鼠 单克隆(15.2)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-107)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2015) ncbi
小鼠 单克隆(6.5B5)
  • 免疫组化; 小鼠; 1:100-1:200; 图 5
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-18853)被用于被用于免疫组化在小鼠样本上浓度为1:100-1:200 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(15.2)
  • 流式细胞仪; 人类; 图 2
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-107)被用于被用于流式细胞仪在人类样本上 (图 2). Mol Cancer (2015) ncbi
小鼠 单克隆(15.2)
  • 其他; 人类; 图 1
圣克鲁斯生物技术ICAM-1抗体(Santa cruz biotechnology, SC-107)被用于被用于其他在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(G-5)
  • 免疫组化-石蜡切片; 人类; 4 ug/ml; 图 s7
  • 免疫印迹; 人类; 300 ng/ml; 图 5a
圣克鲁斯生物技术ICAM-1抗体(Santa cruz, sc-8439)被用于被用于免疫组化-石蜡切片在人类样本上浓度为4 ug/ml (图 s7) 和 被用于免疫印迹在人类样本上浓度为300 ng/ml (图 5a). Mol Cancer (2015) ncbi
小鼠 单克隆(G-5)
  • 免疫印迹; 大鼠; 1:500; 图 7c
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-8439)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 7c). Mol Med Rep (2015) ncbi
小鼠 单克隆(15.2)
  • 免疫组化-石蜡切片; 小鼠; 图 1
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-107)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 1). J Exp Med (2014) ncbi
小鼠 单克隆(G-5)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-8439)被用于被用于免疫印迹在人类样本上 (图 1). Basic Res Cardiol (2014) ncbi
小鼠 单克隆(15.2)
  • 免疫组化; 人类; 1:50
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-107)被用于被用于免疫组化在人类样本上浓度为1:50. PLoS ONE (2014) ncbi
小鼠 单克隆(LB-2)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-18908)被用于被用于免疫细胞化学在人类样本上. J Neurosci Methods (2014) ncbi
小鼠 单克隆(G-5)
  • 免疫组化-石蜡切片; 小鼠; 1:400
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz, sc-8439)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400. J Mol Cell Cardiol (2014) ncbi
小鼠 单克隆(6.5B5)
  • 免疫印迹; 人类
圣克鲁斯生物技术ICAM-1抗体(Santa Cruz Biotechnology, sc-18853)被用于被用于免疫印迹在人类样本上. Free Radic Biol Med (2014) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR16608)
  • 免疫组化-石蜡切片; 小鼠; 图 2a
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab179707)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a). J Clin Med (2020) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫印迹; 人类; 1:2000; 图 3c
艾博抗(上海)贸易有限公司ICAM-1抗体(abcam, ab53013)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3c). BMC Cardiovasc Disord (2019) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫印迹; 人类; 图 5k
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab53013)被用于被用于免疫印迹在人类样本上 (图 5k). Sci Rep (2018) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫组化-石蜡切片; 人类; 图 1
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab53013)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, an53013)被用于被用于免疫印迹在人类样本上 (图 2). Pflugers Arch (2016) ncbi
小鼠 单克隆(15.2)
  • 抑制或激活实验; 人类; 图 2
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab20)被用于被用于抑制或激活实验在人类样本上 (图 2). MBio (2016) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫组化; 人类; 1:250; 图 s9h
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab53013)被用于被用于免疫组化在人类样本上浓度为1:250 (图 s9h). Oncotarget (2016) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 免疫组化-冰冻切片; 人类; 图 s1c
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab53013)被用于被用于免疫组化-冰冻切片在人类样本上 (图 s1c). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(15.2)
  • 免疫印迹; 人类; 图 2a
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab20)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Mol Med (2016) ncbi
小鼠 单克隆(MEM-111)
  • 免疫印迹; 大鼠; 图 7
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫印迹在大鼠样本上 (图 7). Acta Pharmacol Sin (2016) ncbi
domestic rabbit 单克隆(EP1442Y)
  • 流式细胞仪; 人类; 图 3
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, EP1442Y)被用于被用于流式细胞仪在人类样本上 (图 3). J Virol (2016) ncbi
小鼠 单克隆(MEM-111)
  • 免疫组化-石蜡切片; 人类; 1:20; 图 1c
  • 免疫组化; 小鼠; 1:200; 图 1b
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20 (图 1c) 和 被用于免疫组化在小鼠样本上浓度为1:200 (图 1b). Nat Commun (2015) ncbi
小鼠 单克隆(MEM-111)
  • 免疫印迹; 大鼠; 图 6
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫印迹在大鼠样本上 (图 6). Free Radic Biol Med (2015) ncbi
小鼠 单克隆(MEM-111)
  • 免疫细胞化学; 人类; 1:100; 表 1
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (表 1). Acta Biomater (2015) ncbi
小鼠 单克隆(MEM-111)
  • 免疫组化-石蜡切片; 大鼠; 1:100
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:100. Mol Pharm (2014) ncbi
小鼠 单克隆(MEM-111)
  • 免疫印迹; 大鼠; 1:2000
艾博抗(上海)贸易有限公司ICAM-1抗体(Abcam, ab2213)被用于被用于免疫印迹在大鼠样本上浓度为1:2000. Evid Based Complement Alternat Med (2013) ncbi
BioLegend
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 8s1a
BioLegendICAM-1抗体(BioLegend, HA58)被用于被用于流式细胞仪在人类样本上 (图 8s1a). elife (2019) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类; 图 1c
BioLegendICAM-1抗体(BioLegend, HCD54)被用于被用于流式细胞仪在人类样本上 (图 1c). BMC Immunol (2019) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 表 3
BioLegendICAM-1抗体(BioLegend, HA58)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(HA58)
  • 免疫沉淀; 人类; 图 4e
  • 免疫组化; 人类; 图 5a
BioLegendICAM-1抗体(BioLegend, 353105)被用于被用于免疫沉淀在人类样本上 (图 4e) 和 被用于免疫组化在人类样本上 (图 5a). Oncotarget (2017) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类
BioLegendICAM-1抗体(BioLegend, HCD54)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类; 图 2a
BioLegendICAM-1抗体(Biolegend, HCD54)被用于被用于流式细胞仪在人类样本上 (图 2a). Eur J Immunol (2016) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类; 图 3c
BioLegendICAM-1抗体(Biolegend, HCD54)被用于被用于流式细胞仪在人类样本上 (图 3c). J Immunol (2016) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 4
BioLegendICAM-1抗体(BioLegend, 353108)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类
BioLegendICAM-1抗体(Biolegend, 322708)被用于被用于流式细胞仪在人类样本上. Vascul Pharmacol (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 4
BioLegendICAM-1抗体(Biolegend, 353108)被用于被用于流式细胞仪在人类样本上 (图 4). J Neuroinflammation (2015) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类; 图 6
BioLegendICAM-1抗体(Biolegend, HCD54)被用于被用于流式细胞仪在人类样本上 (图 6). PLoS Pathog (2015) ncbi
小鼠 单克隆(HCD54)
  • 免疫细胞化学; 人类
BioLegendICAM-1抗体(BioLegend, 322708)被用于被用于免疫细胞化学在人类样本上. Pharmacol Rep (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
BioLegendICAM-1抗体(BioLegend, HA58)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
BioLegendICAM-1抗体(BioLegend, HA58)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HCD54)
  • 流式细胞仪; 人类; 表 1
BioLegendICAM-1抗体(Biolegend, HCD54)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
安迪生物R&D
小鼠 单克隆(BBIG-I1 (11C81))
  • 免疫细胞化学; 人类; 1:200; 图 6b
安迪生物R&DICAM-1抗体(R&D Systems, BBIG-I1)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 6b). Tissue Eng Part C Methods (2017) ncbi
小鼠 单克隆(BBIG-I1 (11C81))
  • 免疫印迹; 人类; 图 2c
安迪生物R&DICAM-1抗体(R&D Systems, BBA3)被用于被用于免疫印迹在人类样本上 (图 2c). Oncotarget (2017) ncbi
小鼠 单克隆(BBIG-I1 (11C81))
  • 流式细胞仪; 人类; 1:200; 图 1
安迪生物R&DICAM-1抗体(R&D, BBIG-1)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1). J Inflamm (Lond) (2016) ncbi
小鼠 单克隆(BBIG-I1 (11C81))
  • 免疫组化; 小鼠; 1:200; 图 5a
  • 免疫印迹; 人类; 1:1000; 图 6g
安迪生物R&DICAM-1抗体(R&D systems, BBIG-I1)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 5a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 6g). Nat Commun (2015) ncbi
小鼠 单克隆(BBIG-I1 (11C81))
  • 流式细胞仪; 人类; 图 3
安迪生物R&DICAM-1抗体(R&D Systems, BBA3)被用于被用于流式细胞仪在人类样本上 (图 3). Oncotarget (2015) ncbi
domestic goat 多克隆
安迪生物R&DICAM-1抗体(R and D Systems, BBA17)被用于. PLoS ONE (2015) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(15.2)
  • 抑制或激活实验; 大鼠; 图 7a
伯乐(Bio-Rad)公司ICAM-1抗体(AbD Serotec, 1A29 or 15.2)被用于被用于抑制或激活实验在大鼠样本上 (图 7a). J Immunol (2017) ncbi
小鼠 单克隆(15.2)
  • 抑制或激活实验; 人类; 图 6
伯乐(Bio-Rad)公司ICAM-1抗体(Abd Serotec, MCA1615EL)被用于被用于抑制或激活实验在人类样本上 (图 6). Toxicol In Vitro (2014) ncbi
小鼠 单克隆(15.2)
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类
伯乐(Bio-Rad)公司ICAM-1抗体(AbD Serotec, MCA1615GA)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上. Cytotechnology (2014) ncbi
小鼠 单克隆(15.2)
伯乐(Bio-Rad)公司ICAM-1抗体(AbDSerotec, MCA1615EL)被用于. PLoS ONE (2013) ncbi
美天旎
人类 单克隆(REA266)
  • 流式细胞仪; 人类; 图 s2
美天旎ICAM-1抗体(Miltenyi Biotec, REA266)被用于被用于流式细胞仪在人类样本上 (图 s2). Toxicol Appl Pharmacol (2018) ncbi
人类 单克隆(REA266)
  • 流式细胞仪; 人类; 图 2e
美天旎ICAM-1抗体(Miltenyi Biotec, REA266)被用于被用于流式细胞仪在人类样本上 (图 2e). Int J Mol Sci (2017) ncbi
LifeSpan Biosciences
小鼠 单克隆(MEM-111)
  • 免疫组化-石蜡切片; 大鼠; 图 5
  • 免疫组化; 大鼠
LifeSpan BiosciencesICAM-1抗体(Lifespan Bioscience Inc, LS-B1850)被用于被用于免疫组化-石蜡切片在大鼠样本上 (图 5) 和 被用于免疫组化在大鼠样本上. PLoS ONE (2016) ncbi
武汉三鹰
domestic rabbit 多克隆
武汉三鹰ICAM-1抗体(Proteintech, 10831-1-AP)被用于. Cancer Lett (2015) ncbi
Tonbo Biosciences
单克隆(15.2)
  • 流式细胞仪; 人类; 图 3b
Tonbo BiosciencesICAM-1抗体(Tonbo Biosciences, 15.2)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncotarget (2017) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1 ug/ml; 图 2c
赛信通(上海)生物试剂有限公司ICAM-1抗体(Cell Signaling, 4915S)被用于被用于免疫印迹在人类样本上浓度为1 ug/ml (图 2c). Arterioscler Thromb Vasc Biol (2016) ncbi
碧迪BD
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 1:5; 图 5a
碧迪BDICAM-1抗体(BD Biosciences, 555512)被用于被用于流式细胞仪在人类样本上浓度为1:5 (图 5a). Sci Rep (2020) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 s4g
碧迪BDICAM-1抗体(BD, 560971)被用于被用于流式细胞仪在人类样本上 (图 s4g). Cell Death Differ (2019) ncbi
小鼠 单克隆(HA58)
  • 抑制或激活实验; 人类; 5 ug/ml; 图 3b
碧迪BDICAM-1抗体(BD, HA58)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml (图 3b). Nature (2017) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 1:200; 图 3c
碧迪BDICAM-1抗体(BD Biosciences, HA58)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 3c). J Immunol (2017) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 1:500; 图 5
碧迪BDICAM-1抗体(BD Biosciences, 555510)被用于被用于流式细胞仪在人类样本上浓度为1:500 (图 5). MBio (2016) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 1:100; 图 6
碧迪BDICAM-1抗体(BD Bioscience, 559771)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 6). Nat Commun (2016) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 st1
碧迪BDICAM-1抗体(BD, 555511)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(LB-2)
  • 流式细胞仪; 人类; 图 1a
碧迪BDICAM-1抗体(BD Biosciences, LB-2)被用于被用于流式细胞仪在人类样本上 (图 1a). Br J Cancer (2016) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 表 s1
碧迪BDICAM-1抗体(BD Pharmingen, BD559771)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
碧迪BDICAM-1抗体(BD Biosciences, 559771)被用于被用于流式细胞仪在人类样本上. J Tissue Eng Regen Med (2017) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 s4
碧迪BDICAM-1抗体(BD Pharmingen, 555510)被用于被用于流式细胞仪在人类样本上 (图 s4). Stem Cell Reports (2015) ncbi
小鼠 单克隆(LB-2)
  • 流式细胞仪; 人类
碧迪BDICAM-1抗体(BD Pharmingen, LB-2)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 图 2
碧迪BDICAM-1抗体(BD Biosciences, HA58)被用于被用于流式细胞仪在人类样本上 (图 2). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类; 1:50
碧迪BDICAM-1抗体(Becton Dickenson, HA58)被用于被用于流式细胞仪在人类样本上浓度为1:50. PLoS ONE (2014) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
碧迪BDICAM-1抗体(BD Biosciences, HA58)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HA58)
  • 流式细胞仪; 人类
碧迪BDICAM-1抗体(Becton Dickinson, 555512)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(LB-2)
  • 流式细胞仪; 人类; 图 5
碧迪BDICAM-1抗体(BD, LB-2)被用于被用于流式细胞仪在人类样本上 (图 5). J Tissue Eng Regen Med (2015) ncbi
文章列表
  1. Barruet E, Garcia S, Striedinger K, Wu J, Lee S, Byrnes L, et al. Functionally heterogeneous human satellite cells identified by single cell RNA sequencing. elife. 2020;9: pubmed 出版商
  2. Messias C, Loss Morais G, Carvalho J, Gonzalez M, Cunha D, Vasconcelos Z, et al. Zika virus targets the human thymic epithelium. Sci Rep. 2020;10:1378 pubmed 出版商
  3. Lin C, Lin W, Cho R, Yang C, Yeh Y, Hsiao L, et al. Induction of HO-1 by Mevastatin Mediated via a Nox/ROS-Dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE Cascade Suppresses TNF-α-Induced Lung Inflammation. J Clin Med. 2020;9: pubmed 出版商
  4. Liu Y, Tie L. Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway. BMC Cardiovasc Disord. 2019;19:279 pubmed 出版商
  5. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed 出版商
  6. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed 出版商
  7. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed 出版商
  8. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed 出版商
  9. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed 出版商
  10. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed 出版商
  11. Dorraji S, Hovd A, Kanapathippillai P, Bakland G, Eilertsen G, Figenschau S, et al. Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. Sci Rep. 2018;8:7861 pubmed 出版商
  12. Mussotter F, Potratz S, Budczies J, Luch A, Haase A. A multi-omics analysis reveals metabolic reprogramming in THP-1 cells upon treatment with the contact allergen DNCB. Toxicol Appl Pharmacol. 2018;340:21-29 pubmed 出版商
  13. Padilla J, Carpenter A, Das N, Kandikattu H, López Ongil S, Martinez Lemus L, et al. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol. 2018;314:H52-H64 pubmed 出版商
  14. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  15. Horn A, Celic I, Dong C, Martirosyan I, Han J. A conserved role for the ESCRT membrane budding complex in LINE retrotransposition. PLoS Genet. 2017;13:e1006837 pubmed 出版商
  16. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed 出版商
  17. Martinez Moreno J, Herencia C, de Oca A, Díaz Tocados J, Vergara N, Gómez Luna M, et al. High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives. Clin Sci (Lond). 2017;131:1449-1463 pubmed 出版商
  18. Dragoni S, Hudson N, Kenny B, Burgoyne T, McKenzie J, Gill Y, et al. Endothelial MAPKs Direct ICAM-1 Signaling to Divergent Inflammatory Functions. J Immunol. 2017;198:4074-4085 pubmed 出版商
  19. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed 出版商
  20. Prasad S, Sajja R, Kaisar M, Park J, Villalba H, Liles T, et al. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol. 2017;12:58-69 pubmed 出版商
  21. Chimen M, Yates C, McGettrick H, Ward L, Harrison M, Apta B, et al. Monocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface. J Immunol. 2017;198:2834-2843 pubmed 出版商
  22. Gamal W, Treskes P, Samuel K, Sullivan G, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep. 2017;7:37541 pubmed 出版商
  23. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  24. Ganesan M, Finsterwalder R, Leb H, Resch U, Neumüller K, de Martin R, et al. Three-Dimensional Coculture Model to Analyze the Cross Talk Between Endothelial and Smooth Muscle Cells. Tissue Eng Part C Methods. 2017;23:38-49 pubmed 出版商
  25. Monsuur H, Weijers E, Niessen F, Gefen A, Koolwijk P, Gibbs S, et al. Extensive Characterization and Comparison of Endothelial Cells Derived from Dermis and Adipose Tissue: Potential Use in Tissue Engineering. PLoS ONE. 2016;11:e0167056 pubmed 出版商
  26. Bonan S, Albrengues J, Grasset E, Kuzet S, Nottet N, Bourget I, et al. Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts. Oncotarget. 2017;8:1304-1320 pubmed 出版商
  27. Di Paola R, Fusco R, Gugliandolo E, Crupi R, Evangelista M, Granese R, et al. Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis. Front Pharmacol. 2016;7:382 pubmed
  28. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed 出版商
  29. Bæk R, Søndergaard E, Varming K, Jørgensen M. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods. 2016;438:11-20 pubmed 出版商
  30. Naidenow J, Hrgovic I, Doll M, Hailemariam Jahn T, Lang V, Kleemann J, et al. Peroxisome proliferator-activated receptor (PPAR) ? and ? activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. J Inflamm (Lond). 2016;13:27 pubmed 出版商
  31. Aldabbous L, Abdul Salam V, McKinnon T, Duluc L, Pepke Zaba J, Southwood M, et al. Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension. Arterioscler Thromb Vasc Biol. 2016;36:2078-87 pubmed 出版商
  32. Pannier D, Philippin Lauridant G, Baranzelli M, Bertin D, Bogart E, Delprat V, et al. High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer. Oncol Lett. 2016;12:1422-1428 pubmed
  33. Broniarek I, Koziel A, Jarmuszkiewicz W. The effect of chronic exposure to high palmitic acid concentrations on the aerobic metabolism of human endothelial EA.hy926 cells. Pflugers Arch. 2016;468:1541-54 pubmed 出版商
  34. Avril M, Bernabeu M, Benjamin M, Brazier A, Smith J. Interaction between Endothelial Protein C Receptor and Intercellular Adhesion Molecule 1 to Mediate Binding of Plasmodium falciparum-Infected Erythrocytes to Endothelial Cells. MBio. 2016;7: pubmed 出版商
  35. Ferrer Torres D, Nancarrow D, Kuick R, Thomas D, Nadal E, Lin J, et al. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas. Oncotarget. 2016;7:54867-54882 pubmed 出版商
  36. Sabry S, Vuillaumier Barrot S, Mintet E, Fasseu M, Valayannopoulos V, Heron D, et al. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. Orphanet J Rare Dis. 2016;11:84 pubmed 出版商
  37. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  38. Pal P, Daniels B, Oskman A, Diamond M, Klein R, Goldberg D. Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio. 2016;7: pubmed 出版商
  39. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed 出版商
  40. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed 出版商
  41. Kwon O, Kim K, Lee E, Kim M, Choi S, Li H, et al. Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. PLoS ONE. 2016;11:e0154942 pubmed 出版商
  42. Wang Y, Cao J, Fan Y, Xie Y, Xu Z, Yin Z, et al. Artemisinin inhibits monocyte adhesion to HUVECs through the NF-?B and MAPK pathways in vitro. Int J Mol Med. 2016;37:1567-75 pubmed 出版商
  43. Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed 出版商
  44. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  45. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed 出版商
  46. Zhang Y, Ma X, Guo C, Wang M, Kou N, Qu H, et al. Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization. Acta Pharmacol Sin. 2016;37:463-72 pubmed 出版商
  47. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  48. Wiltshire R, Nelson V, Kho D, Angel C, O Carroll S, Graham E. Regulation of human cerebro-microvascular endothelial baso-lateral adhesion and barrier function by S1P through dual involvement of S1P1 and S1P2 receptors. Sci Rep. 2016;6:19814 pubmed 出版商
  49. Yeh P, Huang H, Yang C, Yang W, Yang C. Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats. PLoS ONE. 2016;11:e0146438 pubmed 出版商
  50. Luna C, Carmona A, Alique M, Carracedo J, Ramirez R. TNFα-Damaged-HUVECs Microparticles Modify Endothelial Progenitor Cell Functional Activity. Front Physiol. 2015;6:395 pubmed 出版商
  51. Roth Flach R, Skoura A, Matevossian A, Danai L, Zheng W, Cortes C, et al. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nat Commun. 2015;6:8995 pubmed 出版商
  52. Sugiyama M, Gamage A, Zyla R, Armstrong S, Advani S, Advani A, et al. Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury. J Virol. 2016;90:1812-23 pubmed 出版商
  53. Andzinski L, Kasnitz N, Stahnke S, Wu C, Gereke M, von Köckritz Blickwede M, et al. Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 2016;138:1982-93 pubmed 出版商
  54. Amigo Jiménez I, Bailón E, Aguilera Montilla N, Terol M, García Marco J, García Pardo A. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Oncotarget. 2015;6:44832-48 pubmed 出版商
  55. Kraut B, Maier H, Kókai E, Fiedler K, Boettger T, Illing A, et al. Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 2015;10:e0141591 pubmed 出版商
  56. Qiu H, Liu B, Liu W, Liu S. Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells. Mol Cell Biochem. 2016;411:1-10 pubmed 出版商
  57. Galore Haskel G, Nemlich Y, Greenberg E, Ashkenazi S, Hakim M, Itzhaki O, et al. A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme. Oncotarget. 2015;6:28999-9015 pubmed 出版商
  58. Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A, et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015;6:7967 pubmed 出版商
  59. Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155 pubmed 出版商
  60. Chalubinski M, Wojdan K, Luczak E, Gorzelak P, Borowiec M, Gajewski A, et al. IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms. Vascul Pharmacol. 2015;73:57-63 pubmed 出版商
  61. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed 出版商
  62. McCormick S, He Q, Stern J, Khodarev N, Weichselbaum R, Skelly C. Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia. PLoS ONE. 2015;10:e0130264 pubmed 出版商
  63. Kasper J, Hermanns M, Unger R, Kirkpatrick C. A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. J Tissue Eng Regen Med. 2017;11:1285-1297 pubmed 出版商
  64. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed 出版商
  65. Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog. 2015;11:e1004906 pubmed 出版商
  66. Koizume S, Ito S, Nakamura Y, Yoshihara M, Furuya M, Yamada R, et al. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Mol Cancer. 2015;14:77 pubmed 出版商
  67. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed 出版商
  68. Clark P, Kim R, Pober J, Kluger M. Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-κB-dependent phases. PLoS ONE. 2015;10:e0120075 pubmed 出版商
  69. Luo C, Yuan D, Zhao W, Chen H, Luo G, Su G, et al. Sevoflurane ameliorates intestinal ischemia-reperfusion-induced lung injury by inhibiting the synergistic action between mast cell activation and oxidative stress. Mol Med Rep. 2015;12:1082-90 pubmed 出版商
  70. Bawadekar M, de Andrea M, Lo Cigno I, Baldanzi G, Caneparo V, Graziani A, et al. The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation. J Interferon Cytokine Res. 2015;35:441-53 pubmed 出版商
  71. Skowron W, Zemanek K, Wojdan K, Gorzelak P, Borowiec M, Broncel M, et al. The effect of interleukin-35 on the integrity, ICAM-1 expression and apoptosis of human aortic smooth muscle cells. Pharmacol Rep. 2015;67:376-81 pubmed 出版商
  72. Irwin D, Baek J, Hassell K, Nuss R, Eigenberger P, Lisk C, et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015;82:50-62 pubmed 出版商
  73. Yao Y, Wei W, Sun J, Chen L, Deng X, Ma L, et al. Proteomic analysis of exosomes derived from human lymphoma cells. Eur J Med Res. 2015;20:8 pubmed 出版商
  74. Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, et al. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol. 2015;180:383-92 pubmed 出版商
  75. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  76. Johnstone S, Liley M, Dalby M, Barnett S. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater. 2015;13:266-76 pubmed 出版商
  77. Mou W, Xu Y, Ye Y, Chen S, Li X, Gong K, et al. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. Cancer Lett. 2015;358:115-23 pubmed 出版商
  78. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  79. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed 出版商
  80. Å krnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed 出版商
  81. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-63 pubmed 出版商
  82. Balasa B, Yun R, Belmar N, Fox M, Chao D, Robbins M, et al. Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways. Cancer Immunol Immunother. 2015;64:61-73 pubmed 出版商
  83. Miyabe Y, Miyabe C, Iwai Y, Yokoyama W, Sekine C, Sugimoto K, et al. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. Arthritis Res Ther. 2014;16:461 pubmed 出版商
  84. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Karbach J, et al. Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leuk Res. 2014;38:1332-41 pubmed 出版商
  85. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed 出版商
  86. Fork C, Hitzel J, Nichols B, Tikkanen R, Brandes R. Flotillin-1 facilitates toll-like receptor 3 signaling in human endothelial cells. Basic Res Cardiol. 2014;109:439 pubmed 出版商
  87. Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501 pubmed 出版商
  88. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  89. Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014;11:3503-14 pubmed 出版商
  90. Toutounchian J, Steinle J, Makena P, Waters C, Wilson M, Haik B, et al. Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. PLoS ONE. 2014;9:e100210 pubmed 出版商
  91. Hu N, Mora Jensen H, Theilgaard Monch K, Doornbos van der Meer B, Huitema M, Stegeman C, et al. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS ONE. 2014;9:e99671 pubmed 出版商
  92. Montoya Rodríguez A, Milán Carrillo J, Dia V, Reyes Moreno C, Gonzalez de Mejia E. Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway. Proteome Sci. 2014;12:30 pubmed 出版商
  93. Takeshita Y, Obermeier B, Cotleur A, Sano Y, Kanda T, Ransohoff R. An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods. 2014;232:165-72 pubmed 出版商
  94. Poussin C, Gallitz I, Schlage W, Steffen Y, Stolle K, Lebrun S, et al. Mechanism of an indirect effect of aqueous cigarette smoke extract on the adhesion of monocytic cells to endothelial cells in an in vitro assay revealed by transcriptomics analysis. Toxicol In Vitro. 2014;28:896-908 pubmed 出版商
  95. Chen R, Zhang F, Song L, Shu Y, Lin Y, Dong L, et al. Transcriptome profiling reveals that the SM22?-regulated molecular pathways contribute to vascular pathology. J Mol Cell Cardiol. 2014;72:263-72 pubmed 出版商
  96. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  97. Valente A, Irimpen A, Siebenlist U, Chandrasekar B. OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. Free Radic Biol Med. 2014;70:117-28 pubmed 出版商
  98. Fakhrudin N, Waltenberger B, Cabaravdic M, Atanasov A, Malainer C, Schachner D, et al. Identification of plumericin as a potent new inhibitor of the NF-?B pathway with anti-inflammatory activity in vitro and in vivo. Br J Pharmacol. 2014;171:1676-86 pubmed 出版商
  99. Ding L, Zhang Z, Shang D, Cheng J, Yuan H, Wu Y, et al. ?-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J Oral Pathol Med. 2014;43:335-43 pubmed 出版商
  100. Duan H, Huang J, Li W, Tang M. Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid Based Complement Alternat Med. 2013;2013:408268 pubmed 出版商
  101. Tang X, Richardson W, Fitch R, Brown C, Isaacs R, Chen J. A new non-enzymatic method for isolating human intervertebral disc cells preserves the phenotype of nucleus pulposus cells. Cytotechnology. 2014;66:979-86 pubmed 出版商
  102. Berger S, Turner L, Wang C, Petersen J, Kraft M, Lusingu J, et al. Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1. PLoS ONE. 2013;8:e69117 pubmed 出版商
  103. Li X, Marcondes A, Ragoczy T, Telling A, Deeg H. Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice. Blood Cancer J. 2013;3:e113 pubmed 出版商
  104. Denecke B, Horsch L, Radtke S, Fischer J, Horn P, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering. J Tissue Eng Regen Med. 2015;9:E84-97 pubmed 出版商
  105. Perdomo Arciniegas A, Vernot J. Co-culture of hematopoietic stem cells with mesenchymal stem cells increases VCAM-1-dependent migration of primitive hematopoietic stem cells. Int J Hematol. 2011;94:525-32 pubmed 出版商
  106. Farias V, Linares Fernández J, Peñalver J, Payá Colmenero J, Ferrón G, Duran E, et al. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta. 2011;32:86-95 pubmed 出版商
  107. Lee D, Li H, Ochoa M, Tanaka M, Carbone R, Damoiseaux R, et al. Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis. 2010;201:558-69 pubmed 出版商
  108. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  109. Fromm J, Kussick S, Wood B. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting. Am J Clin Pathol. 2006;126:764-80 pubmed
  110. Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, et al. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. J Cell Physiol. 2006;207:354-63 pubmed
  111. Zhang F, Marcus W, Goyal N, Selvaraj P, Springer T, Zhu C. Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem. 2005;280:42207-18 pubmed
  112. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, et al. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. J Immunol Methods. 2005;305:20-32 pubmed
  113. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, et al. Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol. 2005;204:113-23 pubmed
  114. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  115. Ito T, Kumamoto T, Horinouchi H, Yukishige K, Sugihara R, Fujimoto S, et al. Adhesion molecule expression in experimental myositis. Muscle Nerve. 2002;25:409-18 pubmed
  116. Semnani R, Sabzevari H, Iyer R, Nutman T. Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun. 2001;69:5813-22 pubmed